Our History & Vision

Founded in 1992, Silver Lake Research has a proud history of continuous innovation, introducing transformative diagnostic solutions for human and animal health, environmental monitoring, and food safety. Today, our US-based development and manufacturing facilities produce millions of tests per year, with a robust pipeline promising an exciting future. Through partnerships, collaborations, strategic investments, and groundbreaking research, we continue to pave the way for transformational solutions in diagnostics and beyond.

At Silver Lake Research, we use our powerful Enhanced Affinity Platform to create diverse monoclonal antibody (MAb) panels for detection of traditionally “difficult” or non-immunogenic targets. The EAP™ System was designed to generate a massive immune response to any target antigen – orders of magnitude more potent than standard immunization schemes.

SLR’s engineering expertise and vertical integration allow for the cost-effective development and manufacturing of simple, rapid, and highly sensitive lateral flow assay (LFA) test strips. These LFAs bring the power of laboratory testing into the palm of your hand, for confident antigen detection, at home or in the field. Importantly, the resulting rapid test kit products are affordable even in resource-constrained regions of the world.

Since 1992, SLR has been a global industry leader in MAb and LFA development. Our rapid test products are sold on six continents and are being deployed by governmental organizations and NGOs for public health screening and veterinary disease surveillance. Our outstanding track record of success in contract development projects makes us a trusted resource for government and private-sector partners. We look forward to collaborating with your group to develop the next important rapid test.